Chapter
DEFINITION OF HYPOTENSION
PATHOGENESIS AND DIAGNOSIS OF PATHOLOGIC CEREBRAL BLOOD FLOW
SUMMARY AND RECOMMENDATIONS
Chapter 3 Intraventricular Hemorrhage and White Matter Injury in the Preterm Infant
PERIVENTRICULAR-INTRAVENTRICULAR HEMORRHAGE
WHITE MATTER INJURY IN THE ABSENCE OF HEMORRHAGE
Chapter 4 Posthemorrhagic Hydrocephalus Management Strategies
QUESTION 1. WHAT MEASUREMENTS OF VENTRICULAR SIZE ARE USED IN DIAGNOSIS OF PHVD?
QUESTION 2. HOW CAN WE DISTINGUISH VENTRICULAR DILATATION DRIVEN BY CSF UNDER PRESSURE FROM VENTRICULAR DILATATION DUE TO LOSS OF PERIVENTRICULAR WHITE MATTER?
QUESTION 3. HOW DO WE DEFINE EXCESSIVE HEAD ENLARGEMENT?
QUESTION 4. HOW DO WE RECOGNIZE RAISED INTRACRANIAL PRESSURE?
QUESTION 5. WHAT IS INFANT A’S PROGNOSIS?
QUESTION 6. WHAT IS THE MECHANISM OF PHVD?
QUESTION 7. HOW CAN PHVD INJURE WHITE MATTER?
QUESTION 8. WHAT INTERVENTIONS HAVE BEEN USED IN PHVD AND IS THERE ANY EVIDENCE OF IMPROVING OUTCOME?
OBJECTIVES IN TREATING PHVD
CURRENT MANAGEMENT STRATEGY
AREAS WHERE FURTHER RESEARCH IS NEEDED
Chapter 5 Brain Cooling for Neonatal Encephalopathy: Potential Indications for Use
ENCEPHALOPATHY AND HYPOXIA-ISCHEMIA
PATHOGENESIS OF HYPOXIC-ISCHEMIC BRAIN INJURY
DIAGNOSIS OF NEONATAL HIE
OUTCOME FOLLOWING NEONATAL HIE
POTENTIAL THERAPIES FOR NEONATAL HIE
CLINICAL EXPERIENCE WITH BRAIN COOLING FOR HIE
CLINICAL APPLICATION OF BRAIN COOLING
Chapter 6 General Supportive Management of the Term Infant with Neonatal Encephalopathy Following Intrapartum Hypoxia-Ischemia
EARLY IDENTIFICATION OF INFANTS AT HIGHEST RISK OF DEVELOPING HYPOXIC-ISCHEMIC BRAIN INJURY
Chapter 7 Stroke in the Fetus and Neonate
Chapter 8 Diagnosis and Treatment of Neonatal Seizures
RECOGNITION OF NEONATAL SEIZURES
CLINICAL SEIZURE CRITERIA
NONEPILEPTIC BEHAVIORS OF NEONATES
ELECTROGRAPHIC SEIZURE CRITERIA
SUBCORTICAL SEIZURES VERSUS NONICTAL FUNCTIONAL DECORTICATION
SEIZURES IN THE CLINICAL CONTEXT OF MATERNAL–FETAL–PLACENTAL DISEASES: FOLLOWING A DIAGNOSTIC ALGORITHM
Chapter 9 Glucose and Perinatal Brain Injury: Questions and Controversies
GLUCOSE METABOLISM IN THE FETUS AND NEWBORN
CEREBRAL METABOLISM OF GLUCOSE
SYMPTOMATIC VERSUS ASYMPTOMATIC HYPOGLYCEMIA
HYPOGLYCEMIA AND BRAIN DAMAGE
Chapter 10 Neonatal Hypotonia
PHYSICAL EXAMINATION AND ASSESSMENT OF A HYPOTONIC CHILD
DIFFERENTIAL ANATOMIC DIAGNOSIS OF HYPOTONIA
COMMON NEUROMUSCULAR DISORDERS PRESENTING PRINCIPALLY WITH HYPOTONIA
Chapter 11 Hyperbilirubinemia and the Risk for Brain Injury
APPROACHES: STRATEGIES FOR DIAGNOSIS AND TREATMENT
RECOMMENDATIONS FOR TREATMENT
Chapter 12 Neonatal Meningitis: Current Treatment Options
QUESTION 1. WHAT RISK FACTORS PREDISPOSE THIS INFANT TO HAVE EARLY-ONSET BACTERIAL MENINGITIS?
QUESTION 2. DO INFANTS WITH MENINGITIS HAVE POSITIVE BLOOD CULTURES?
QUESTION 3. WHAT IS THE OPTIMAL EVALUATION FOR POSSIBLE LATE-ONSET SEPSIS IN PRETERM INFANTS IN THE NICU?
QUESTION 4. WHAT IS THE EMPIRICAL ANTIMICROBIAL CHOICE FOR POSSIBLE LATE-ONSET SEPSIS IN THE NICU?
QUESTION 5. WHAT IS THE TREATMENT OF MENINGITIS IN NEONATES, AND IN PARTICULAR THAT DUE TO GRAM-NEGATIVE BACILLI?
QUESTION 6. SHOULD OTHER THERAPIES BE CONSIDERED?
QUESTION 7. WHAT IS THE DURATION OF TREATMENT FOR MENINGITIS IN NEONATES?
QUESTION 8. WHEN SHOULD NEUROIMAGING BE CONSIDERED AND WHAT TYPE OF EXAMINATION IS RECOMMENDED?
QUESTION 9. SHOULD OTHER ADJUNCTIVE THERAPIES BE PROVIDED TO AN INFANT WITH MENINGITIS?
QUESTION 10. WHAT IF THE INFANT’S CSF IS ABNORMAL BUT ROUTINE BACTERIAL CULTURES OF CSF AND BLOOD ARE STERILE?
QUESTION 11. WHAT IS THE OUTCOME OF MENINGITIS IN NEONATES?
Chapter 13 Magnetic Resonance Imaging’s Role in the Care of the Infant at Risk for Brain Injury
Chapter 14 Long-term Follow-up of Very Low Birth Weight Infants
OUTCOME: CEREBRAL PALSY AND OTHER NEUROLOGIC OR SENSORY SEQUELAE
THE 18- TO 24-MONTH-OLD CHILD
THE 3- TO 6-YEAR-OLD CHILD
THE ADOLESCENT AND YOUNG ADULT